Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors

Veterinary Pathology

Volumn 40, Issue 1, 2003, Pages 55-62

  Ramos Vara, J A ^a   Miller, M A ^a   Boucher, M ^a   Roudabush, A ^a   Johnson, G C ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Cytokeratin 20; Cytokeratin 7; Dogs; Immunohistochemistry; Neoplasia; Urinary bladder; Uroplakin III

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; UROPLAKIN III; INTERMEDIATE FILAMENT PROTEIN; KERATIN; MEMBRANE PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG DISEASE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; METASTASIS; NONHUMAN; PROTEIN EXPRESSION; TUMOR LOCALIZATION; UROGENITAL TRACT TUMOR; ANIMAL; ANIMAL DISEASE; BLADDER TUMOR; DOG; METABOLISM; PAPILLOMA; PATHOLOGY; TISSUE FIXATION; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

ANIMALIA; CANIS FAMILIARIS;

ANIMALS; CARCINOMA, TRANSITIONAL CELL; DOG DISEASES; DOGS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; MEMBRANE GLYCOPROTEINS; PAPILLOMA; TISSUE FIXATION; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0037268696     PISSN: 03009858     EISSN: None     Source Type: Journal    
DOI: 10.1354/vp.40-1-55     Document Type: Article

References (34)

1. Adachi W, Okubo K, Kinoshita S: Human uroplakin Ib in ocular surface epithelium. Invest Ophthalmol Vis Sci 41:2900-2905, 2000
2. Alroy J, Pauli BU, Hayden JE, Gould VE: Intracytoplasmic lumina in bladder carcinomas. Hum Pathol 10:549-555, 1979
3. Ambrosio V, Borzacchiello G, Bruno F, Galati P, Roperto F: Uroplakin expression in the urothelial tumors of cows. Vet Pathol 38:657-660, 2001
4. Banks WJ: Epithelia. In: Applied Veterinary Histology, 3rd ed., pp. 48-67. Mosby Year Book, St. Louis, MO, 1993
5. Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA: Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol 113:383-388, 2000
6. Bostwick DG, Quian J, Ramnani DM: Prostate and bladder. In: Diagnostic Immunohistochemistry, ed. Dabbs DJ, pp. 407-458. Churchill Livingstone, New York, NY, 2002
7. Chu P, Wu E, Weiss LM: Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 13:962-972, 2000
8. Eble JN, Young RH: Tumors of the urinary tract. In: Diagnostic Histopathology of Tumors, ed. Fletcher CDM, vol. 1, pp. 475-565. Churchill Livingstone, London, UK, 2000
9. Espinosa de los Monteros A, Fernández A, Millán MY, Rodríguez F, Herráez P, Martín de las Mulas J: Coordinate expression of cytokeratins 7 and 20 in feline and canine carcinomas. Vet Pathol 36:179-190, 1999
10. Gitlin JS, Wu X-R, Sun T-T, Ritchey ML, Shapiro E: New concepts of histological changes in experimental augmentation cystoplasty: insights into the development of neoplastic transformation at the enterovesical and gastrovesical anastomosis. J Urol 162:1096-1100, 1999
11. Harnden P, Allam A, Joyce AD, Patel A, Selby P, Southgate J: Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent disease. Histopathology 27:169-174, 1995
12. Kaufmann O, Volmerig J, Dietel M: Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol 113:683-687, 2000
13. Kunze E, Francksen B: Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical study. Urol Res 30:66-78, 2002
14. Kunze E, Francksen B, Schulz H: Expression of MUC5AC apomucin in transitional cell carcinomas of the urinary bladder and its possible role in the development of mucus-secreting adenocarcinomas. Virchows Arch 439:609-615, 2001
15. Liebert M, Gebhardt D, Wood C, Chen I-L L, Ellard J, Amancio D, Grossman HB: Urothelial differentiation and bladder cancer. In: Advances in Bladder Research, eds. Baskin LS, Hayward SW, pp. 437-448. Kluwer Academic, New York, NY, 1999
16. Meuten DJ: Tumors of the urinary system. In: Tumors in Domestic Animals, ed. Meuten DJ, 4th ed., pp. 509-546, Iowa State Press, Ames, IA, 2002
17. Miettinen M: Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 8:384-388, 1995
18. Moll R, Achtstätter T, Becht E, Balcarova-Ständer J, Ittensohn M, Franke WW: Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines. Am J Pathol 132:123-144, 1988
19. Moll R, Löwe A, Laufer J, Franke WW: Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140:427-447, 1992
20. Moll R, Wu X-R, Lin J-H, Sun T-T: Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am J Pathol 147:1383-1397, 1995
21. Nielsen SW, Moulton JE: Tumors of the urinary system. In: Tumors in Domestic Animals, ed. Moulton JE, 3rd ed., pp. 458-478. University of California Press, Berkeley, CA, 1990
22. Ogawa K, Johansson SL, Cohen SM: Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract. Am J Pathol 155:1047-1050, 1999
23. Ogawa K, St. John M, de Oliveira ML, Arnold L, Shirai T, Sun T-T, Cohen SM: Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats and mice. Toxicol Pathol 27:645-651, 1999
24. Ogawa K, Sun T-T, Cohen SM: Analysis of differentiation-associated proteins in rat bladder carcinogenesis. Carcinogenesis 17:961-965, 1996
25. Ramos-Vara JA, Beissenherz ME: Optimization of immunohistochemical methods using two different antigen retrieval methods on formalin-fixed, paraffin-embedded tissues: experience with 63 markers. J Vet Diagn Invest 12:307-311, 2000
26. Ramos-Vara JA, Miller MA, Johnson GC: Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7. Vet Pathol 38:636-643, 2001
27. Rhodin JAG: Urinary system. In: Histology: A Text and Atlas, pp. 647-674. Oxford University Press, New York, NY, 1974
28. Romith R, Jezernik K, Mašera A: Uroplakins and cytokeratins in the regenerating rat urothelium after sodium saccharin treatment. Histochem Cell Biol 109:263-269, 1998
29. Sun T-T, Liang F-X, Wu X-R: Uroplakins as markers of urothelial differentiation. In: Advances in Bladder Research, ed. Baskin LS, Hayward SW, pp. 7-18. Plenum Publishers Corporation, New York, NY, 1999
30. Troyanovsky SM, Leube RE, Franke WW: Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur J Cell Biol 59:127-137, 1992
31. Valli VE, Norris A, Jacobs RM, Laing E, Withrow S, Macy D, Tomlinson J, McCaw D, Ogilvie GK, Pidgeon G, Henderson RA: Pathology of canine bladder and urethral cancer and correlation with tumour progression and survival. J Comp Pathol 113:113-130, 1995
32. Walz T, Häner M, Wu X-R, Henn C, Engel A, Sun T-T, Aebi U: Towards the molecular architecture of the asymmetric unit membrane of the mammalian urinary bladder epithelium: a closed "twisted ribbon" structure. J Mol Biol 248:887-900, 1995
33. Wu X-R, Lin J-H, Walz T, Häner M, Yu J, Aebi U: Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J Biol Chem 18:13716-13724, 1994
34. Zaloudek C: Tumors of the ovary. In: Diagnostic Histopathology of Tumors, ed. Fletcher CDM, 2nd ed., pp. 567-642. Churchill Livingstone, London, UK, 2000